Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rx, OTC, Supplement Concurrent Use Reported By Half Of Survey Respondents

This article was originally published in The Tan Sheet

Executive Summary

Thirty-nine percent of respondents in a recent survey reported taking an average of 3.73 vitamins, minerals or herbal supplements within the past week.

You may also be interested in...



Pharmacists’ Group Pushes Fundamental Change In Supplement Regulation

Concern about possibly harmful interactions between dietary supplements and drugs has prompted the American Society of Health-System Pharmacists to recommend that Congress fundamentally change the regulation of supplements by requiring pre-market approval of the products

Pharmacists’ Group Pushes Fundamental Change In Supplement Regulation

Concern about possibly harmful interactions between dietary supplements and drugs has prompted the American Society of Health-System Pharmacists to recommend that Congress fundamentally change the regulation of supplements by requiring pre-market approval of the products

Pharmacists’ Group Pushes Fundamental Change In Supplement Regulation

Concern about possibly harmful interactions between dietary supplements and drugs has prompted the American Society of Health-System Pharmacists to recommend that Congress fundamentally change the regulation of supplements by requiring pre-market approval of the products

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092110

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel